Ceolus™ of Asahi Kasei Europe
With their extraordinary compactibility, Ceolus™ UF and KG facilitate formulation design and tableting efficiency – for high-dose, small-tablet, and low-compactibility drug implementations. Standard Ceolus™ PH and colloidal Ceolus™ RC series are widely recognized and trusted for superior function, performance, and quality.
100% MCC spherical seed
Celphere™ is a 100% MCC spherical seed core for drug layering and film coating. It is high in mechanical strength and water absorption and is an optimum seed core for a wide range of aqueous layering and coating systems.
Asahi Kasei Pharmaceutical Excipients
Discover the set of applications
Our pharmaceuticals business provides a wide range of pharmaceuticals and diagnostic reagents. As a specialized, R&D-centered operation, the development of new world-class drugs is advanced to offer innovative and unique therapeutic solutions in the fields of orthopedics, critical/intensive care, urology, the immune system, and the central nervous system.
Our products show a variety of special characteristics ranging from compatibility and flowability to water absorption and even more to guarantee different application possibilities. Have a look at each product and their features and benefits.
Find out even more about our pharmaceutical excipients and request samples on the following website.
Ceolus™ – Microcrystalline Cellulose
Asahi Kasei currently manufactures Ceolus™, a microcrystalline cellulose (MCC excipient) used primarily in pharmaceuticals as tablet binder, in Nobeoka, Miyazaki Prefecture, Japan. Nobeoka is not only the first location for manufacturing MCC but also the birthplace of Asahi Kasei.
Because of a growing demand Asahi Kasei’s Specialty Solutions SBU has established a second plant at its Mizushima Works in Kurashiki, Okayama Prefecture, Japan, in spring 2023.
A broad range of technologies from functional fibers, performance plastics, synthetic rubber, semiconductor devices, to various sensors.
Focus in the fields of orthopedics, critical/intensive care, urology, the immune system, and the central nervous system.